{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:03:22Z","timestamp":1794654202024,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U54CK000482"],"award-info":[{"award-number":["U54CK000482"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1245\/s10434-022-12110-1","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T14:04:36Z","timestamp":1657721076000},"page":"7751-7764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Individualized Risk Prediction Tool for Serious Wound Complications After Mastectomy With and Without Immediate Reconstruction"],"prefix":"10.1245","volume":"29","author":[{"given":"Katelin B.","family":"Nickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence M.","family":"Myckatyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara N.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7070-9320","authenticated-orcid":false,"given":"Margaret A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CDC Prevention Epicenter Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"12110_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1200\/JCO.2013.52.2284","volume":"32","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32:919\u201326.","journal-title":"J Clin Oncol"},{"key":"12110_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/PRS.0b013e3182729cde","volume":"131","author":"CR Albornoz","year":"2013","unstructured":"Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15\u201323.","journal-title":"Plast Reconstr Surg"},{"key":"12110_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","volume":"150","author":"KL Kummerow","year":"2015","unstructured":"Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150:9\u201316.","journal-title":"JAMA Surg"},{"key":"12110_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.breast.2017.10.009","volume":"37","author":"AP Yoon","year":"2018","unstructured":"Yoon AP, Qi J, Brown DL, et al. Outcomes of immediate versus delayed breast reconstruction: results of a multicenter prospective study. Breast. 2018;37:72\u20139.","journal-title":"Breast"},{"key":"12110_CR5","doi-asserted-by":"publisher","first-page":"124e","DOI":"10.1097\/PRS.0b013e318213a2e6","volume":"127","author":"JM Serletti","year":"2011","unstructured":"Serletti JM, Fosnot J, Nelson JA, Disa JJ, Bucky LP. Breast reconstruction after breast cancer. Plast Reconstr Surg. 2011;127:124e-e135.","journal-title":"Plast Reconstr Surg"},{"key":"12110_CR6","doi-asserted-by":"publisher","first-page":"e172338","DOI":"10.1001\/jamasurg.2017.2338","volume":"152","author":"MA Olsen","year":"2017","unstructured":"Olsen MA, Nickel KB, Fox IK, Margenthaler JA, Wallace AE, Fraser VJ. Comparison of wound complications after immediate, delayed, and secondary breast reconstruction procedures. JAMA Surg. 2017;152:e172338.","journal-title":"JAMA Surg"},{"key":"12110_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/PRS.0000000000004547","volume":"142","author":"O Cohen","year":"2018","unstructured":"Cohen O, Lam G, Choi M, Ceradini D, Karp N. Risk factors for delays in adjuvant chemotherapy following immediate breast reconstruction. Plast Reconstr Surg. 2018;142:299\u2013305.","journal-title":"Plast Reconstr Surg"},{"key":"12110_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.amjsurg.2018.10.028","volume":"217","author":"SA Valente","year":"2019","unstructured":"Valente SA, Liu Y, Upadhyaya S, Tu C, Pratt DA. The effect of wound complications following mastectomy with immediate reconstruction on breast cancer recurrence. Am J Surg. 2019;217:514\u20138.","journal-title":"Am J Surg"},{"key":"12110_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/pon.2089","volume":"22","author":"JP Gopie","year":"2013","unstructured":"Gopie JP, Timman R, Hilhorst MT, Hofer SO, Mureau MA, Tibben A. The short-term psychological impact of complications after breast reconstruction. Psychooncology. 2013;22:290\u20138.","journal-title":"Psychooncology"},{"key":"12110_CR10","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1097\/PRS.0b013e318208d0d4","volume":"127","author":"S Colakoglu","year":"2011","unstructured":"Colakoglu S, Khansa I, Curtis MS, et al. Impact of complications on patient satisfaction in breast reconstruction. Plast Reconstr Surg. 2011;127:1428\u201336.","journal-title":"Plast Reconstr Surg"},{"key":"12110_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/archsurg.2007.11","volume":"143","author":"MA Olsen","year":"2008","unstructured":"Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VJ. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143:53\u201360.","journal-title":"Arch Surg"},{"key":"12110_CR12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jamcollsurg.2014.05.012","volume":"219","author":"CR Albornoz","year":"2014","unstructured":"Albornoz CR, Cordeiro PG, Pusic AL, et al. Diminishing relative contraindications for immediate breast reconstruction: a multicenter study. J Am Coll Surg. 2014;219:788\u201395.","journal-title":"J Am Coll Surg"},{"key":"12110_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jso.25714","volume":"120","author":"M Roy","year":"2019","unstructured":"Roy M, Sebastiampillai S, Haykal S, Zhong T, Hofer SOP, O\u2019Neill AC. Development and validation of a risk stratification model for immediate microvascular breast reconstruction. J Surg Oncol. 2019;120:1177\u201383.","journal-title":"J Surg Oncol"},{"key":"12110_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000000351","volume":"3","author":"JY Kim","year":"2015","unstructured":"Kim JY, Mlodinow AS, Khavanin N, et al. Individualized risk of surgical complications: an application of the Breast Reconstruction Risk Assessment Score. Plast Reconstr Surg Glob Open. 2015;3:e405.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"12110_CR15","doi-asserted-by":"publisher","first-page":"273e","DOI":"10.1097\/PRS.0000000000006443","volume":"145","author":"JD Frey","year":"2020","unstructured":"Frey JD, Salibian AA, Choi M, Karp NS. Putting together the pieces: development and validation of a risk-assessment model for nipple-sparing mastectomy. Plast Reconstr Surg. 2020;145:273e-e283.","journal-title":"Plast Reconstr Surg"},{"key":"12110_CR16","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1245\/s10434-021-09710-8","volume":"28","author":"MM Jonczyk","year":"2021","unstructured":"Jonczyk MM, Fisher CS, Babbitt R, et al. Surgical predictive model for breast cancer patients assessing acute postoperative complications: The Breast Cancer Surgery Risk Calculator. Ann Surg Oncol. 2021;28:5121\u201331.","journal-title":"Ann Surg Oncol"},{"key":"12110_CR17","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1245\/s10434-014-4200-x","volume":"22","author":"MA Olsen","year":"2015","unstructured":"Olsen MA, Nickel KB, Margenthaler JA, et al. Increased risk of surgical-site infection among breast-conserving surgery re-excisions. Ann Surg Oncol. 2015;22:2003\u20139.","journal-title":"Ann Surg Oncol"},{"key":"12110_CR18","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1245\/s10434-015-5083-1","volume":"23","author":"MA Olsen","year":"2016","unstructured":"Olsen MA, Nickel KB, Margenthaler JA, et al. Development of a risk prediction model to individualize risk factors for surgical-site infection after mastectomy. Ann Surg Oncol. 2016;23:2471\u20139.","journal-title":"Ann Surg Oncol"},{"key":"12110_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1017\/ice.2020.1288","volume":"42","author":"AAA Bediako-Bowan","year":"2021","unstructured":"Bediako-Bowan AAA, Warren DK, Nickel KB, Fraser VJ, Olsen MA. Clinical implications of restrictions in criteria for defining surgical site infections after mastectomy. Infect Control Hosp Epidemiol. 2021;42:767\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"12110_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris R, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8\u201327.","journal-title":"Med Care"},{"key":"12110_CR21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","volume":"53","author":"CN Klabunde","year":"2000","unstructured":"Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258\u201367.","journal-title":"J Clin Epidemiol"},{"key":"12110_CR22","unstructured":"Cook N. SAS Macros. 2015. Retrieved 25 July 2020 at http:\/\/ncook.bwh.harvard.edu\/sas-macros.html."},{"key":"12110_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1541-0420.2008.01062.x","volume":"65","author":"B Rosner","year":"2009","unstructured":"Rosner B, Glynn RJ. Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models. Biometrics. 2009;65:188\u201397.","journal-title":"Biometrics"},{"key":"12110_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"EW Steyerberg","year":"2009","unstructured":"Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer; 2009."},{"key":"12110_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/aos\/1176344552","volume":"7","author":"B Efron","year":"1979","unstructured":"Efron B. Bootstrap methods: another look at the jackknife. Ann Stat. 1979;7:1\u201326.","journal-title":"Ann Stat"},{"key":"12110_CR26","unstructured":"Harrell F. Comparison of Strategies for Validating Binary Logistic Regression Models. 2018. Retrieved 27 May 2021 at http:\/\/hbiostat.org\/doc\/simval.html."},{"key":"12110_CR27","unstructured":"Lankham I, Slaughter M. A Framework for Simple and Efficient Bootstrap Validation in SAS, with Examples. 2021. Retrieved 25 May 2021 at https:\/\/github.com\/saspy-bffs\/sgf-2021-bootstrap-validation."},{"issue":"Suppl 1","key":"12110_CR28","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.breast.2021.11.018","volume":"62","author":"EH Hersh","year":"2022","unstructured":"Hersh EH, King TA. De-escalating axillary surgery in early-stage breast cancer. Breast. 2022;62(Suppl 1):S43\u20139.","journal-title":"Breast"},{"key":"12110_CR29","doi-asserted-by":"publisher","first-page":"351e","DOI":"10.1097\/PRS.0000000000000439","volume":"134","author":"JY Kim","year":"2014","unstructured":"Kim JY, Khavanin N, Jordan SW, et al. Individualized risk of surgical-site infection: an application of the breast reconstruction risk assessment score. Plast Reconstr Surg. 2014;134:351e-e362.","journal-title":"Plast Reconstr Surg"},{"key":"12110_CR30","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.bjps.2017.04.010","volume":"70","author":"N Khavanin","year":"2017","unstructured":"Khavanin N, Qiu CS, Mlodinow AS, et al. External validation of the breast reconstruction risk assessment calculator. J Plast Reconstr Aesthet Surg. 2017;70:876\u201383.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"12110_CR31","doi-asserted-by":"publisher","first-page":"e2065","DOI":"10.1097\/GOX.0000000000002065","volume":"6","author":"JT Blough","year":"2018","unstructured":"Blough JT, Vu MM, Qiu CS, et al. Beyond 30 days: a risk calculator for longer term outcomes of prosthetic breast reconstruction. Plast Reconstr Surg Glob Open. 2018;6:e2065.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"12110_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jamcollsurg.2018.05.003","volume":"227","author":"N Hansen","year":"2018","unstructured":"Hansen N, Espino S, Blough JT, Vu MM, Fine NA, Kim JYS. Evaluating mastectomy skin flap necrosis in the extended breast reconstruction risk assessment score for 1-year prediction of prosthetic reconstruction outcomes. J Am Coll Surg. 2018;227:96\u2013104.","journal-title":"J Am Coll Surg"},{"issue":"5S Suppl 4","key":"12110_CR33","doi-asserted-by":"publisher","first-page":"S318","DOI":"10.1097\/SAP.0000000000002320","volume":"84","author":"S Martin","year":"2020","unstructured":"Martin S, Turner E, Nguyen A, Thornton B, Nazerali RS. An evaluation of the utility of the breast reconstruction risk assessment score risk model in prepectoral tissue expander breast reconstruction. Ann Plast Surg. 2020;84(5S Suppl 4):S318-22.","journal-title":"Ann Plast Surg"},{"key":"12110_CR34","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.bjps.2019.03.033","volume":"72","author":"AC O\u2019Neill","year":"2019","unstructured":"O\u2019Neill AC, Murphy AM, Sebastiampillai S, Zhong T, Hofer SOP. Predicting complications in immediate microvascular breast reconstruction: validity of the breast reconstruction assessment (BRA) surgical risk calculator. J Plast Reconstr Aesthet Surg. 2019;72:1285\u201391.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"12110_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10549-020-05747-7","volume":"183","author":"GE Naoum","year":"2020","unstructured":"Naoum GE, Oladeru OT, Niemierko A, et al. Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy. Breast Cancer Res Treat. 2020;183:127\u201336.","journal-title":"Breast Cancer Res Treat"},{"key":"12110_CR36","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/jac\/dkab475","volume":"77","author":"MA Olsen","year":"2022","unstructured":"Olsen MA, Greenberg JK, Peacock K, Nickel KB, Fraser VJ, Warren DK. Lack of association of post-discharge prophylactic antibiotics with decreased risk of surgical-site infection following spinal fusion. J Antimicrob Chemother. 2022;77:1178\u201384.","journal-title":"J Antimicrob Chemother"},{"key":"12110_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1017\/ice.2015.108","volume":"36","author":"MA Olsen","year":"2015","unstructured":"Olsen MA, Nickel KB, Fox IK, et al. Incidence of surgical-site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol. 2015;36:907\u201314.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"12110_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1086\/663715","volume":"33","author":"JD Lankiewicz","year":"2012","unstructured":"Lankiewicz JD, Yokoe DS, Olsen MA, et al. Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection? Infect Control Hosp Epidemiol. 2012;33:202\u20134.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12110-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T18:13:13Z","timestamp":1665425593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["12110"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12110-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Margaret A. Olsen reports consultant work and grant funding from Pfizer for work outside the submitted manuscript. Victoria J. Fraser reports that her spouse is the Chief Clinical Officer at Cigna Corporation. Terence M. Myckatyn reports advisory board membership, investigator-initiated grant, and device development royalties for RTI Surgical. He reports former investigator-initiated grants and advisory board work with Allergan, and an unencumbered research award from Sientra. Clara N. Lee was supported by a grant from the Agency for Healthcare Research and Quality (R18 HS026699-01A1). The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}